Arbutus Biopharma (NASDAQ:ABUS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Arbutus Biopharma (ABUS) operate in?

Arbutus Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Arbutus Biopharma Stock (NASDAQ: ABUS) stock price, news, charts, stock research, profile.

Open	$3.80
Close	-
Volume / Avg.	276.35K / 963.01K
Day Range	3.70 - 3.83
52 Wk Range	1.69 - 3.89
Market Cap	$717.13M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	66
Short Interest	4.04%
Days to Cover	4.61

Recent News

Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge

Delaware Judge favors Arbutus and Genevant Sciences in their patent dispute with Moderna over COVID-19 vaccine technology.

Vandana Singh

Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound Ahead

Moderna stock falls 2.32% due to patent infringement suit. However, some investors see this as an opportunity to enter or average out. Golden Cross formation also offers hope for future growth.

Surbhi Jain

Arbutus Stock Soars 20% As It Heads To Trial With Moderna In Covid Vaccine Patent Claim

Arbutus Biopharma soared more than 20% on Wednesday, April 3, after the company received permission to pursue a claim against Moderna in court.

Neil Dennis

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commerci...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Arbutus Biopharma (ABUS) stock?

You can purchase shares of Arbutus Biopharma (NASDAQ:ABUS) through any online brokerage.

View our list of the best stock brokerages

Who are Arbutus Biopharma (ABUS) competitors?

There are no as such competitors for Arbutus Biopharma.

What is the target price for Arbutus Biopharma (ABUS) stock?

There is no analysis for Arbutus Biopharma.

What is the forecast for Arbutus Biopharma (ABUS) stock?

Arbutus Biopharma has a consensus price target of $5.40.

Current stock price for Arbutus Biopharma (ABUS)?

The stock price for Arbutus Biopharma (NASDAQ: ABUS) is $3.8 last updated Today at July 17, 2024 at 9:25 AM EDT.

Does Arbutus Biopharma (ABUS) pay a dividend?

There are no upcoming dividends for Arbutus Biopharma.

When is Arbutus Biopharma (NASDAQ:ABUS) reporting earnings?

Arbutus Biopharma’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Arbutus Biopharma (ABUS) going to split?

There is no upcoming split for Arbutus Biopharma.

What sector and industry does Arbutus Biopharma (ABUS) operate in?

Arbutus Biopharma is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Arbutus Biopharma

Arbutus Biopharma (ABUS) Forecast